mAb
Adalimumab
Adalimumab is an anti-TNF-alpha monoclonal antibody used across immune-mediated inflammatory diseases, presented in prefilled pens and syringes. BOOKPHARM supplies adalimumab biosimilar through technology transfer and drug-substance supply.
Supply offerings
| Business line | Business model | Regulatory status |
|---|---|---|
| APImAb | Tech Transfer + Supply | NMPA approval |
Supplied for pharmaceutical manufacturing and R&D by licensed and qualified entities. Not for human use as supplied. Availability is subject to regulatory approval in the buyer's jurisdiction.